2
nd
Conference Agenda
Annual Personalized Nanomedicine Symposium
Miami, FL
January 29th, 2015
Registration
7:30 AM – 8:00 AM
MARC Pavilion
11200 SW 8 Street, University Park, Florida International University,
Miami
Welcome - Breakfast
8:00 AM – 8:05 AM
Welcome Speech
Karla S. Munoz, MS, MBA
Master of Ceremony - SPNM Secretary
8:05 AM – 8:15 AM
Kenneth Furton, Ph.D.
Provost and Executive Vice President, Florida International University
Chief Operating Officer
8:15 AM – 8:25 AM
John Rock, M.D., M.S.P.H.
Founding Dean, Florida International University Herbert Wertheim College
of Medicine
Senior Vice President for Health Affairs
8:25 AM – 8:30 AM
Madhavan Nair, PhD
SPNM Founding President
Keynote Speaker
8:30 AM – 8: 50 AM Piotr Grodzinski, Ph.D.
Director of Nanotechnology for Cancer Programs at NCI
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Title: Cancer Nanotechnology: Current Status and Future
Opportunities
Introduced by Carolyn Runowicz, M.D.
Executive Associate Dean for Academic Affairs
Professor of Obstetrics and Gynecology
Herbert Wertheim College of Medicine, Florida International University
Former President of American Cancer Society
Session 1
Design and Development of Nanoparticles for Personalized Nanomedicine
Chair: Rao Rapaka, Ph.D.
Branch Chief of Chemistry and Physiological Systems Research Branch (CPSRB)
National Institutes of Health (NIH)
National Institute on Drug Abuse (NIDA)
Chair: Richard Cote, M.D.
Professor and Chairman, Department of Pathology
Director of BioNIUM
University of Miami
8:50 AM – 9:20 AM
Plenary Speech: Nanotech in Personalized Medicine
Larry Nagahara, Ph.D.
Director, Physical Sciences- Oncology
Division of Cancer Biology
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Introduced by: Amir Mirmiranm, Ph.D., PE, ASCE, ACI
Vasant H. Surti Professor and Dean, College of Engineering and Computing
Florida International University
9:20 AM – 9:40 AM
Engineering of Soft Nanomaterials for Drug Delivery in
Cancer
S1: Tatiana Bronich, Ph.D.
Professor and Center for Drug Delivery and Nanomedicine, Codirector
University of Nebraska Medical Center
9:40 AM – 10:00 AM
Conjugated Polymer Nanoparticles for Biomedical Imaging
and Therapeutic Delivery
S2: Joong Ho-Moon, Ph.D.
Associate Professor, Department of Chemistry and Biochemistry
Florida International University
10:00 AM – 10:20 AM
Nanobiology Approach to Protect Neurons from Oxidative
Stress
S3: Anuja Ghorpade, Ph.D.
Chairman and Professor, Cell Biology and Immunology
University of North Texas
10:20 AM – 10:30 AM
BREAK
Session 2
Theranostics for Personalized Nanomedicine
Chair: Larry Nagahara, Ph.D.
Director, Physical Sciences- Oncology
Division of Cancer Biology
National Cancer Institute (NCI)
Chair: Sylvia Daunert, Ph.D.
Professor and Lucille P. Markey Chair, Department of Biochemistry and Molecular Biology
University of Miami
10:30 AM – 10:50 AM
Advanced Manufacturing for Personalized Nanomedicine
Plenary Speech: Kaiming Ye, Ph.D.
Professor and Chair, Department of Bioengineering
Stem Cell and Tissue Engineering Laboratory
Binghamton University
Introduced by: Chenzhong Li, Ph.D.
Associate Professor, Biomedical Engineering
Florida International University
10:50 AM – 11:10 AM
Nanobiotechnology and Nanomotor: Single Pore High
Throughput DNA Sensing, Single Molecule Detection, Single
Fluorescence Imaging, and RNA
Nanotechnology
S1: Peixuan Guo, Ph.D.
Professor
and
William
Farish
Endowed
Chair
in
Nanobiotechnology
Director, Nanobiotechnology Center
University of Kentucky
11:10 AM – 11:30 AM
Quantitative Cardiac Imaging for Cocaine-Induced Subclinical
Atherosclerosis in Patients and Future Perspective
S2: Shenghan Lai, M.D., M.P.H.
Professor of Pathology
Joint of Psychiatry and Behavioral Sciences
Professor of Radiology and Radiological Science
John Hopkins University
11:30 AM – 11:50 AM
NeuroImaging for Theranostics in Personalized Medicine
S3: Matthew Sutherland, Ph.D.
Assistant Professor, Department of Psychology
Florida International University
11:50 AM – 12:10 PM
Targeted Theranostic Nanoparticles for Cancer: Imaging,
Chemotherapy, and Thermotherapy
S4: Anthony McGoron, Ph.D.
Professor, Biomedical Engineering
Undergraduate Program Director
Florida International University
12:10 PM– 1:15 PM
LUNCH BREAK
1:15 PM – 2:30PM
Poster Session
NIDA Workshop- “Early Career Program for Basic Chemists
in Drug Abuse & Addiction Research”
Dr. Kristopher Bough (NIDA)
Dr. Jag Khalsa (NIDA)
Session 3
Nanomedicine for Cancer and Degenerative Disease
Chair: Piotr Grodzinski, Ph.D.
Director of Nanotechnology for Cancer Programs at NCI
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Chair: Howard Fox, M.D., Ph.D.
Professor, Pharmacology and Experimental Neuroscience
Senior Associate Dean, UNMC Research and Development
University of Nebraska Medical Center
2:35 PM – 2:55 PM
Team Science @ BioNIUM
Plenary Speaker: Richard Cote, M.D.
Professor and Chairman, Department of Pathology
University of Miami
Introduced by: Zubin J. Panthaki, M.D.
Professor of Clinical Surgery
Division of Plastic Surgery
Professor of Clinical Orthopedics, and
Associate Program Director for Plastic Surgery Residency Program
Director, Hand Surgery Fellowship
University of Miami
2:55 PM – 3:15 PM
Obstacles to the Cure of HIV-1
S1: Mario Stevenson, Ph.D.
Professor of Medicine
Chief of the Division of Infectious Diseases
University of Miami
3:15 PM – 3:35 PM
Direct reprogramming of Neural Stem Cells and Specific
Neural Precursors: Potential Application and Challenges in
Nanomedicine
S2: Jialin Zheng, M.D.
Professor
Associate Vice Chancellor for Academic Affairs
Associate Dean for Graduate Studies
Director, Asia Pacific Rim Development Program
University of Nebraska Medical Center
3:35 PM – 3:55 PM
Targeting Iron Homeostasis in Ovarian Cancer
S3: Sundaram Ramakrishnan, Ph.D.
Professor, Department of Pharmacology
University of Minnesota
4:00 PM – 4:30 PM
BREAK
Session 4
Applications of Nanomedicine in HIV-1 and in Emerging Infectious Diseases
Chair: Larry Nagahara, Ph.D.
Director, Physical Sciences- Oncology
Trans-NIH Nano Task Force
Division of Cancer Biology
National Cancer Institute (NCI)
National Institutes of Health (NIH)
Chair: Ram Datar, Ph.D.
Associate Professor of Pathology, Biochemistry and Molecular Biology
Co-Director of BioNIUM
University of Miami
Keynote Speaker
4:35 PM – 4:55 PM
Rao Rapaka, Ph.D.
Branch Chief of Chemistry and Physiological Systems Research
Branch (CPSRB)
National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Title: Future for Nanotechnology: NIDA’S Perspective
Introduced by: Andres G. Gil, Ph.D.
Vice President for Research
Professor of Social Work
Florida International University
4:55 PM – 5:15 PM
Nanocure for Neuro-AIDS and Drug Addiction
S1: Madhavan Nair, Ph.D.
Distinguished Professor and Founding Chair, Department of
Immunology
Director, Institute of Neuroimmune Pharmacology
Associate Dean, Biomedical Research
Florida International University
5:15 PM – 5:35 PM
Rapid Nanodetection of Ebola Infection at Point of Care
S2: Aileen Marty, M.D., FACP
Professor, Department of Medicine
Director, FIU Health Travel Medicine Program and Vaccine Clinic
5:35 PM – 5:55 PM
The Role of Autophagy in NeuroAIDS and Therapeutic
Implications
S3: Nazira El-Hage, Ph.D.
Associate Professor, Department of Immunology
Florida International University
5:55 PM – 6:15 PM
Near Infrared Immunoflourescent Guided Identification of
Ghrelin Producing Cell in Gastric Fundus
S4: Raul Rosenthal, M.D.
Professor and Chief of Staff, Department of General Surgery
Cleveland Clinic Florida
6:30 PM – 8:00 PM
DINNER
7:30 PM – 8:00 PM
BUSINESS DINNER (Executive Committee Members only)
8:15 PM
Bus Leaves to Sofitel Miami
January 30th, 2015
8:00 AM – 8:25 AM
8:25 AM – 8:30 AM
BREAKFAST
Richard J. Noel Jr., PhD
Master of Ceremony - SNIP Meetings Committee Chairperson
Session 5
New Frontiers in HIV and Substance Abuse Research – Part I
Chair: Sulie Chang, Ph.D.
Professor, Department of Biological Sciences
Director, Institute of NeuroImmunne Pharmacology
Seton Hall University
Chair: Alexandros Makriyannis, Ph.D.
Professor, Chemistry and Chemical Biology and Pharmaceutical Sciences
George D. Behrakis Endowed Chair in Pharmaceutical Biotechnology
Director of the Center for Drug Discovery
Northeastern University
8:30 AM – 8:50 AM
Drug Abuse and HIV Research at NIDA/Consequences and
Clinical Management
Plenary Speaker: Jag Khalsa, Ph.D.
Chief, Medical Consequences Branch
Division of Pharmacotherapies and Medical Consequences
National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Introduced by: Raul Gonzalez, Ph.D.
Associate Professor, Department of Psychology
Director, Substance Use and HIV Neuropsychology Lab
8:50 AM – 9: 10 AM
HIV and Morphine Mediated Neuronal Dysfunctions: Blaming
the Messenger
S1: Shilpa Buch, Ph.D.
Professor and Vice-Chair of Research, Department of
Pharmacology and Experimental Neuroscience
University of Nebraska Medical Center
9:10 AM – 9:30 AM
Gene Editing Strategy for Eradicating HIV-1 from Latently
Infected Human Cells
S2: Kamel Khalili, Ph.D.
Laura H. Carnell Professor and Chair, Department of
Neuroscience
Director, Center for Neurovirology
Director, Comprehensive NeuroAIDS Center
Temple University School of Medicine
9:30 AM – 9:50 AM
HIV Interaction with Cocaine and Tat: Epigenetic and
Neuroinflammation
S3: Johnny He, Ph.D
Professor, Department of Cell Biology and Immunology
Associate Dean, GSBS
University of North Texas Health Science Center
9:50 AM – 10:10 AM
Transcriptome Profiling and Pathway Analysis of Genes
Differentially Expressed in the Brain of HIV-1 Transgenic Rats
Treated with Nicotine
S4: Ming Li, Ph.D.
Professor, Psychiatry and Neurobehavioral Sciences
University of Virginia
10:10 AM – 10:30 AM
BREAK
Session 6
New Frontiers in HIV and Substance Abuse Research – Part II
Chair: Lena Al-Harthi, Ph.D.
Professor and Associate Chair, Department of Immunology and Microbiology
Rush University
Chair: Mahendra Kumar, Ph.D.
Professor, Psychiatry and Behavioral Sciences and Psychology
Director, Molecular Neuroendocrinology and Neurotransmitters Laboratory
Chief, Laboratory of Psychoneuroendocrinology
University of Miami
10:35 AM – 10:55 AM
Can a Better Understanding of Endogenous Nano-systems
inform the development of Nanomedicine?
Plenary Speaker: Norman J. Haughey, Ph.D.
Professor, Department of Neurology
Division of Neuroimmunology and Neurological Infections
Director, JHU NIMH Surrogate Markers Core
John Hopkins University School of Medicin
Introduced by: Mohan Sopori, Ph.D.
Clinical Professor and Senior Scientist, College of Pharmacy
Program Manager, Respiratory Immunology and Asthma
Program, Love Lace Respiratory Research Institute,
University of New Mexico
10:55 AM – 11:15 AM
Novel Viral Determinants of HIV-1 Associated Neurocognitive
Disorders
S1: Vinayaka Prasad, Ph.D.
Professor, Department of Microbiology and Immunology
Director, Einstein’s AIDS International Training and Research
Program
Albert Einstein College of Medicine
11:15 AM – 11:35 AM
Pericyte Dysfunctions in BBB impairment Caused by HIV
infection
S2: Yuri Persidsky, M.D., Ph.D.
Chairperson and Professor, Department of Pathology and
Laboratory Medicine
Temple University
11:35 AM – 11:55 AM
Role of Novel Endolysosome Mechanisms in Pathogenesis of
AD and HAND
S3: Jonathan Geiger, Ph.D.
Chester Fritz Distinguished Professor
Interim Chair, Department of Anatomy and Cell Biology
Chair, Department of Pharmacology, Physiology and
Therapeutics
University of North Dakota
11:55 AM – 12:15 PM
Perspective for Nanotoxicology in Future Medicine
S4: Michal Toborek, M.D., Ph.D.
Professor and Vice Chair for Research, Department of
Biochemistry and Molecular Biology
University of Miami
12:15 PM – 1:10 PM
LUNCH
Session 7
Early Investigators in Personalized Nanomedicine Research
Chair: Kristopher Bough, Ph.D.
Tobacco Regulatory Science Program (TRSP) Coordinator/HAS;
Division of Neuroscience and Behavioral Research,
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
Chair: Sanjay Maggirwar, M.B.A., Ph.D
Professor and Vice Chair, Department of Microbiology and Immunology (SMD)
University of Rochester Medical Center
1:15 PM – 1:25 PM
Anti-HIV
Dual Loaded Sustained Release Core-Shell Nanoparticles for
Therapy
S1: Jessica Reynolds, PhD
University of Buffalo
1:25 PM – 1:35 PM
Nanoengineered Sustained Release Formulation for the CNS
Viral Reservoir Eradication
S2: Rahul Dev Jayant, PhD
Florida International University
1:35 PM – 1:45 PM
Brain-Derived Growth Factor (BDNF) signaling: Possible
implications for BDNF bound magnetic nano carriers for the
treatment of stroke
S3: Pallab Bhattacharya, PhD
University of Miami
1:45 PM – 1:55 PM
Influence of Hyperthermia on Nanoparticle Transport
Dynamics in 2D-Monolayer cultures and 3-D Tumor spheroids
S4: Abhignyan Nagesetti, MS
Florida International University
2:00 PM – 2:45 PM
Panel Discussion:
2:45 PM – 3:30 PM
Award Ceremony
3:30 PM – 3:40 PM
Closing Remarks
Jag Khalsa, Ph.D.
Tatiana Bronich, PhD
Sabita Roy, Ph.D
Ram Datar, Ph.D.
Michal Toborek, M.D., Ph.D.